John Treanor

1.3k total citations
8 papers, 1.0k citations indexed

About

John Treanor is a scholar working on Epidemiology, Genetics and Infectious Diseases. According to data from OpenAlex, John Treanor has authored 8 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 3 papers in Genetics and 1 paper in Infectious Diseases. Recurrent topics in John Treanor's work include Respiratory viral infections research (6 papers), Influenza Virus Research Studies (5 papers) and Virus-based gene therapy research (2 papers). John Treanor is often cited by papers focused on Respiratory viral infections research (6 papers), Influenza Virus Research Studies (5 papers) and Virus-based gene therapy research (2 papers). John Treanor collaborates with scholars based in United States, Switzerland and Belgium. John Treanor's co-authors include Robert B. Belshe, Barbara J. Howe, Gary Dubin, Christian Van Hoecke, Frances K. Newman, William C. Gruber, Janet Wittes, Dominick Iacuzio, Pedro A. Piedra and James C. King and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and The Journal of Pediatrics.

In The Last Decade

John Treanor

8 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Treanor United States	8	790	290	264	120	78	8	1.0k
Steve Rockman Australia	14	441 0.6×	293 1.0×	240 0.9×	130 1.1×	43 0.6×	26	777
Karen Kotloff United States	7	1.5k 1.9×	403 1.4×	502 1.9×	103 0.9×	115 1.5×	8	1.7k
Diane O’Brien United States	7	642 0.8×	267 0.9×	205 0.8×	102 0.8×	88 1.1×	10	765
Rajeev Dhere India	16	500 0.6×	95 0.3×	339 1.3×	122 1.0×	32 0.4×	60	868
W Keitel United States	18	744 0.9×	318 1.1×	309 1.2×	265 2.2×	62 0.8×	28	1.2k
Arvydas Ambrozaitis Lithuania	15	512 0.6×	230 0.8×	215 0.8×	113 0.9×	18 0.2×	43	847
Emileigh Johnson United States	13	1.1k 1.4×	255 0.9×	355 1.3×	161 1.3×	117 1.5×	21	1.2k
François Roman Belgium	17	680 0.9×	367 1.3×	385 1.5×	150 1.3×	89 1.1×	44	1.0k
Michel Janssens Belgium	16	364 0.5×	463 1.6×	284 1.1×	234 1.9×	21 0.3×	32	973
Linda Fritts United States	19	360 0.5×	423 1.5×	321 1.2×	115 1.0×	34 0.4×	33	957

Countries citing papers authored by John Treanor

Since Specialization

Citations

This map shows the geographic impact of John Treanor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Treanor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Treanor more than expected).

Fields of papers citing papers by John Treanor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Treanor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Treanor. The network helps show where John Treanor may publish in the future.

Co-authorship network of co-authors of John Treanor

This figure shows the co-authorship network connecting the top 25 collaborators of John Treanor. A scholar is included among the top collaborators of John Treanor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Treanor. John Treanor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Treanor, John, et al.. (2020). A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose. Vaccine. 38(36). 5842–5850. 26 indexed citations

Stephenson, Kathryn E., Michael C. Keefer, Catherine A. Bunce, et al.. (2018). First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. PLoS ONE. 13(11). e0205139–e0205139. 28 indexed citations

Treanor, John, et al.. (2017). Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study. Vaccine. 35(15). 1856–1864. 29 indexed citations

Jackson, Lisa A., Alejandra Gurtman, Martin van Cleeff, et al.. (2013). Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine. 31(35). 3594–3602. 130 indexed citations

Halperin, Scott A., et al.. (2005). A Phase I, Randomized, Controlled Trial to Study the Reactogenicity and Immunogenicity of a Nasal, Inactivated Trivalent Influenza Virus Vaccine in Healthy Adults. Human Vaccines. 1(1). 37–42. 22 indexed citations

Belshe, Robert B., Frances K. Newman, John Treanor, et al.. (2004). Serum Antibody Responses after Intradermal Vaccination against Influenza. New England Journal of Medicine. 351(22). 2286–2294. 272 indexed citations

Treanor, John. (2004). Influenza Vaccine — Outmaneuvering Antigenic Shift and Drift. New England Journal of Medicine. 350(3). 218–220. 183 indexed citations

Belshe, Robert B., William C. Gruber, Paul M. Mendelman, et al.. (2000). Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. The Journal of Pediatrics. 136(2). 168–175. 340 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact